Insider Transactions in Q4 2023 at Mineralys Therapeutics, Inc. (MLYS)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 11
2023
|
David Malcom Rodman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,018
+20.0%
|
$0
$0.54 P/Share
|
|
Nov 22
2023
|
Jon Congleton Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,250
+0.4%
|
$21,250
$5.97 P/Share
|
|
Nov 13
2023
|
David Malcom Rodman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,017
+25.0%
|
$0
$0.54 P/Share
|
|
Nov 03
2023
|
David Malcom Rodman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,034
+50.0%
|
$0
$0.54 P/Share
|